As global markets experience a rebound, with major U.S. stock indexes climbing higher due to cooling inflation and robust bank earnings, the spotlight is on small-cap stocks that could benefit from ...

SEOUL, Jan. 15 (Yonhap) -- SK Biopharmaceuticals Co. (SK Biopharm), a biopharmaceutical arm of SK Group, will establish a joint venture with a major South American biopharma, Eurofarma, in the United ...

Korea’s top biopharmaceutical firms, Celltrion and Samsung Biologics, envisioned their future strategies for expansion at J.P.Morgan Healthcare Conference (JPM) 2025 in San Francisco, Wednesday.

SAN FRANCISCO -- SK Biopharmaceuticals plans to establish a joint venture with Eurofarma, one of Latin America’s leading pharmaceutical companies, to commercialize a new AI-based epilepsy ...

SK Biopharmaceuticals and Eurofarma formed a joint venture to develop an AI platform for managing epilepsy. The focus ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

1 Day 326030 0.09% DJIA 0.34% S&P 500 -0.40% Health Care/Life Sciences 0.43% ...

In Canada, 1 in 12 people live with a rare disease, and for most people suffering from these diseases, the cost of treatment is unaffordable. Canadians deserve a health care system that provides ...